INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 53 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $330,000 | +179.7% | 173,690 | +195.6% | 0.00% | – |
| Q1 2017 | $118,000 | -97.4% | 58,758 | -92.0% | 0.00% | -100.0% |
| Q4 2016 | $4,499,000 | -17.6% | 737,627 | +28.0% | 0.00% | 0.0% |
| Q3 2016 | $5,461,000 | +1203.3% | 576,110 | +923.3% | 0.00% | – |
| Q2 2016 | $419,000 | +22.2% | 56,300 | +21.3% | 0.00% | – |
| Q1 2016 | $343,000 | +281.1% | 46,397 | +151.6% | 0.00% | – |
| Q2 2015 | $90,000 | – | 18,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|